San Francisco, CA, United States of America

Ellen Filvaroff

USPTO Granted Patents = 80 

 

 

Average Co-Inventor Count = 7.1

ph-index = 13

Forward Citations = 655(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Treatment
Biomarkers
Hepatocellular Carcinoma
Aminopurine Compounds
Vascular Development
IL-17 Polypeptides
WISP Polypeptides
Monoclonal Antibodies
TGF-beta Antibodies
Polypeptide Therapeutics
Cartilage Disorders
Nucleic Acids
80 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Ellen Filvaroff - Leading the Way in Hematological Malignancy Treatments

Introduction: Ellen Filvaroff, a pioneering inventor based in San Francisco, CA, has made significant contributions to the field of medicine with a focus on treating hematological malignancies. With an impressive portfolio of 77 patents, Filvaroff continues to drive innovation in the healthcare industry.

Latest Patents: Among her latest patents is the groundbreaking invention of Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use. This patent introduces novel methods for treating, preventing, or managing hematological malignancies by combining (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione with a second active agent.

Career Highlights: Ellen Filvaroff has made remarkable contributions during her tenure at renowned companies such as Genentech, Inc. and Celgene Corporation. Her innovative work in pharmaceutical research has revolutionized the treatment landscape for hematological malignancies.

Collaborations: Throughout her career, Filvaroff has collaborated with esteemed professionals in the field, including Audrey Goddard and William I Wood. Together, they have worked towards advancing cancer treatment strategies and utilizing biomarkers to predict clinical sensitivity to therapies.

Conclusion: Ellen Filvaroff's dedication to advancing medical research and developing innovative treatments for hematological malignancies has solidified her position as a trailblazer in the healthcare industry. Her prolific patent portfolio reflects her commitment to making a meaningful impact on patients' lives and reshaping the future of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…